Minerva Neurosciences, Inc. 8-K

What Happened

• On May 5, 2026, Minerva Neurosciences, Inc. (NERV) announced and furnished a press release with its financial results for the quarter ended March 31, 2026. The press release is attached to the Form 8‑K as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: May 5, 2026 (Current Report on Form 8‑K).
• Reporting period: Quarter ended March 31, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition; press release furnished as Exhibit 99.1.
• The filing also includes the interactive XBRL cover page (Exhibit 104) listed under Item 9.01.

Why It Matters

• This 8‑K provides Minerva’s most recent quarterly results and any related management commentary—key information for assessing recent earnings, revenue, cash position and near‑term prospects.
• Investors should review the attached press release (Exhibit 99.1) for the specific financial figures, any change in guidance, and management remarks that could affect the stock. The 8‑K itself furnishes the release rather than amending other SEC filings.